Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy
Authors:
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 11 (4) , 1069-1082
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (NSFC31500809)
- National Natural Science Foundation of China (NSFC31771096)
- National Natural Science Foundation of China (NSFC31871008)
- National Natural Science Foundation of China (31930067)
- Sichuan University (ZYGD18002)
- West China Hospital, Sichuan University (18HXBH038)
- China Postdoctoral Science Foundation (2018M643484)
- National Science Fund for Distinguished Young Scholars (NSFC31525009)
This publication has 46 references indexed in Scilit:
- 顺铂耐药的分子机制SCIENTIA SINICA Chimica, 2014
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biologyAdvanced Drug Delivery Reviews, 2014
- Surface Charge Switchable Nanoparticles Based on Zwitterionic Polymer for Enhanced Drug Delivery to TumorAdvanced Materials, 2012
- The secret ally: immunostimulation by anticancer drugsNature Reviews Drug Discovery, 2012
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProceedings of the National Academy of Sciences, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Immunogenic and tolerogenic cell deathNature Reviews Immunology, 2009
- Calreticulin exposure dictates the immunogenicity of cancer cell deathNature Medicine, 2006
- The role of glutathione in cancerCell Biochemistry and Function, 2004
- The Influence of the Axial Ligands of a Series of Platinum(IV) Anti-Cancer Complexes on Their Reduction to Platinum(II) and Reaction With DNAAustralian Journal of Chemistry, 1995